Title 21

PART 1 SUBPART M

Subpart M - Accreditation of Third-Party Certification Bodies To Conduct Food Safety Audits and To Issue Certifications Source:80 FR 74650, Nov. 27, 2015, unless otherwise noted.

21:1.0.1.1.1.12.47SUBJGRP 47
Recognition of Accreditation Bodies Under This Subpart
21:1.0.1.1.1.12.47.1SECTION 1.600
   1.600 What definitions apply to this subpart
21:1.0.1.1.1.12.47.2SECTION 1.601
   1.601 Who is subject to this subpart
21:1.0.1.1.1.12.47.3SECTION 1.610
   1.610 Who is eligible to seek recognition
21:1.0.1.1.1.12.47.4SECTION 1.611
   1.611 What legal authority must an accreditation body have to qualify for recognition
21:1.0.1.1.1.12.47.5SECTION 1.612
   1.612 What competency and capacity must an accreditation body have to qualify for recognition
21:1.0.1.1.1.12.47.6SECTION 1.613
   1.613 What protections against conflicts of interest must an accreditation body have to qualify for recognition
21:1.0.1.1.1.12.47.7SECTION 1.614
   1.614 What quality assurance procedures must an accreditation body have to qualify for recognition
21:1.0.1.1.1.12.47.8SECTION 1.615
   1.615 What records procedures must an accreditation body have to qualify for recognition
21:1.0.1.1.1.12.48SUBJGRP 48
Requirements for Accreditation Bodies That Have Been Recognized Under This Subpart
21:1.0.1.1.1.12.48.9SECTION 1.620
   1.620 How must a recognized accreditation body evaluate third-party certification bodies seeking accreditation
21:1.0.1.1.1.12.48.10SECTION 1.621
   1.621 How must a recognized accreditation body monitor the performance of third-party certification bodies it accredited
21:1.0.1.1.1.12.48.11SECTION 1.622
   1.622 How must a recognized accreditation body monitor its own performance
21:1.0.1.1.1.12.48.12SECTION 1.623
   1.623 What reports and notifications must a recognized accreditation body submit to FDA
21:1.0.1.1.1.12.48.13SECTION 1.624
   1.624 How must a recognized accreditation body protect against conflicts of interest
21:1.0.1.1.1.12.48.14SECTION 1.625
   1.625 What records requirements must an accreditation body that has been recognized meet
21:1.0.1.1.1.12.49SUBJGRP 49
Procedures for Recognition of Accreditation Bodies Under This Subpart
21:1.0.1.1.1.12.49.15SECTION 1.630
   1.630 How do I apply to FDA for recognition or renewal of recognition
21:1.0.1.1.1.12.49.16SECTION 1.631
   1.631 How will FDA review my application for recognition or renewal of recognition and what happens once FDA decides on my application
21:1.0.1.1.1.12.49.17SECTION 1.632
   1.632 What is the duration of recognition
21:1.0.1.1.1.12.49.18SECTION 1.633
   1.633 How will FDA monitor recognized accreditation bodies
21:1.0.1.1.1.12.49.19SECTION 1.634
   1.634 When will FDA revoke recognition
21:1.0.1.1.1.12.49.20SECTION 1.635
   1.635 What if I want to voluntarily relinquish recognition or do not want to renew recognition
21:1.0.1.1.1.12.49.21SECTION 1.636
   1.636 How do I request reinstatement of recognition
21:1.0.1.1.1.12.50SUBJGRP 50
Accreditation of Third-Party Certification Bodies Under This Subpart
21:1.0.1.1.1.12.50.22SECTION 1.640
   1.640 Who is eligible to seek accreditation
21:1.0.1.1.1.12.50.23SECTION 1.641
   1.641 What legal authority must a third-party certification body have to qualify for accreditation
21:1.0.1.1.1.12.50.24SECTION 1.642
   1.642 What competency and capacity must a third-party certification body have to qualify for accreditation
21:1.0.1.1.1.12.50.25SECTION 1.643
   1.643 What protections against conflicts of interest must a third-party certification body have to qualify for accreditation
21:1.0.1.1.1.12.50.26SECTION 1.644
   1.644 What quality assurance procedures must a third-party certification body have to qualify for accreditation
21:1.0.1.1.1.12.50.27SECTION 1.645
   1.645 What records procedures must a third-party certification body have to qualify for accreditation
21:1.0.1.1.1.12.51SUBJGRP 51
Requirements for Third-Party Certification Bodies That Have Been Accredited Under This Subpart
21:1.0.1.1.1.12.51.28SECTION 1.650
   1.650 How must an accredited third-party certification body ensure its audit agents are competent and objective
21:1.0.1.1.1.12.51.29SECTION 1.651
   1.651 How must an accredited third-party certification body conduct a food safety audit of an eligible entity
21:1.0.1.1.1.12.51.30SECTION 1.652
   1.652 What must an accredited third-party certification body include in food safety audit reports
21:1.0.1.1.1.12.51.31SECTION 1.653
   1.653 What must an accredited third-party certification body do when issuing food or facility certifications
21:1.0.1.1.1.12.51.32SECTION 1.654
   1.654 When must an accredited third-party certification body monitor an eligible entity that it has issued a food or facility certification
21:1.0.1.1.1.12.51.33SECTION 1.655
   1.655 How must an accredited third-party certification body monitor its own performance
21:1.0.1.1.1.12.51.34SECTION 1.656
   1.656 What reports and notifications must an accredited third-party certification body submit
21:1.0.1.1.1.12.51.35SECTION 1.657
   1.657 How must an accredited third-party certification body protect against conflicts of interest
21:1.0.1.1.1.12.51.36SECTION 1.658
   1.658 What records requirements must a third-party certification body that has been accredited meet
21:1.0.1.1.1.12.52SUBJGRP 52
Procedures for Accreditation of Third-Party Certification Bodies Under This Subpart
21:1.0.1.1.1.12.52.37SECTION 1.660
   1.660 Where do I apply for accreditation or renewal of accreditation by a recognized accreditation body and what happens once the recognized accreditation body decides on my application
21:1.0.1.1.1.12.52.38SECTION 1.661
   1.661 What is the duration of accreditation by a recognized accreditation body
21:1.0.1.1.1.12.52.39SECTION 1.662
   1.662 How will FDA monitor accredited third-party certification bodies
21:1.0.1.1.1.12.52.40SECTION 1.663
   1.663 How do I request an FDA waiver or waiver extension for the 13-month limit for audit agents conducting regulatory audits
21:1.0.1.1.1.12.52.41SECTION 1.664
   1.664 When would FDA withdraw accreditation
21:1.0.1.1.1.12.52.42SECTION 1.665
   1.665 What if I want to voluntarily relinquish accreditation or do not want to renew accreditation
21:1.0.1.1.1.12.52.43SECTION 1.666
   1.666 How do I request reaccreditation
21:1.0.1.1.1.12.53SUBJGRP 53
Additional Procedures for Direct Accreditation of Third-Party Certification Bodies Under This Subpart
21:1.0.1.1.1.12.53.44SECTION 1.670
   1.670 How do I apply to FDA for direct accreditation or renewal of direct accreditation
21:1.0.1.1.1.12.53.45SECTION 1.671
   1.671 How will FDA review my application for direct accreditation or renewal of direct accreditation and what happens once FDA decides on my application
21:1.0.1.1.1.12.53.46SECTION 1.672
   1.672 What is the duration of direct accreditation
21:1.0.1.1.1.12.54SUBJGRP 54
Requirements for Eligible Entities Under This Subpart
21:1.0.1.1.1.12.54.47SECTION 1.680
   1.680 How and when will FDA monitor eligible entities
21:1.0.1.1.1.12.54.48SECTION 1.681
   1.681 How frequently must eligible entities be recertified
21:1.0.1.1.1.12.55SUBJGRP 55
General Requirements of This Subpart
21:1.0.1.1.1.12.55.49SECTION 1.690
   1.690 How will FDA make information about recognized accreditation bodies and accredited third-party certification bodies available to the public
21:1.0.1.1.1.12.55.50SECTION 1.691
   1.691 How do I request reconsideration of a denial by FDA of an application or a waiver request
21:1.0.1.1.1.12.55.51SECTION 1.692
   1.692 How do I request internal agency review of a denial of an application or waiver request upon reconsideration
21:1.0.1.1.1.12.55.52SECTION 1.693
   1.693 How do I request a regulatory hearing on a revocation of recognition or withdrawal of accreditation
21:1.0.1.1.1.12.55.53SECTION 1.694
   1.694 Are electronic records created under this subpart subject to the electronic records requirements of part 11 of this chapter
21:1.0.1.1.1.12.55.54SECTION 1.695
   1.695 Are the records obtained by FDA under this subpart subject to public disclosure
21:1.0.1.1.1.12.56SUBJGRP 56
Requirements for User Fees Under This Subpart
21:1.0.1.1.1.12.56.55SECTION 1.700
   1.700 Who is subject to a user fee under this subpart
21:1.0.1.1.1.12.56.56SECTION 1.705
   1.705 What user fees are established under this subpart
21:1.0.1.1.1.12.56.57SECTION 1.710
   1.710 How will FDA notify the public about the fee schedule
21:1.0.1.1.1.12.56.58SECTION 1.715
   1.715 When must a user fee required by this subpart be submitted
21:1.0.1.1.1.12.56.59SECTION 1.720
   1.720 Are user fees under this subpart refundable
21:1.0.1.1.1.12.56.60SECTION 1.725
   1.725 What are the consequences of not paying a user fee under this subpart on time